1don MSN
Abbott stock is on pace for worst day since 2000. The nutrition business is a drag on earnings.
Abbott reports fourth-quarter sales that miss analysts’ estimates.
In recent weeks, Abbott Laboratories raised its quarterly dividend for the 52nd consecutive year and secured CE Mark approval ...
The Medical Devices business remained a standout performer at Abbott, with Q4 sales up 12.3% to $5.68 billion. Though BTIG ...
Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.
Abbott is teaming up with AtaCor Medical to develop a next-generation implantable cardioverter defibrillator (ICD) designed ...
Abbott Park, Ill.-based Abbott Laboratories and Saint Paul, Minn.-based St. Jude Medical — which Abbott is in the process of acquiring for $25 billion — plan to sell several medical devices to ...
GlobalData on MSN
Abbott’s stock falls by nearly 11% following Q4 sales miss
Abbott missed analysts’ profit expectations for Q4 2025, yet the company’s full year financials were buoyed by strong ...
Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. While Abbott Laboratories saw sales fall in the first ...
Diversified health care company Abbott beat profit expectations for the first quarter with strong medical device sales and a rebounding baby formula business. Abbott reported adjusted earnings per ...
July 20 (Reuters) - Abbott Laboratories (ABT.N), opens new tab on Thursday beat quarterly profit expectations as a rebound in surgical procedure volumes drove demand for medical devices despite high ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results